Abstract
Practice Gap: Timely and accurate recognition of collagen vascular disorders (CVDs), and implementation of effective screening and referral processes for patients suspected of having a CVD, remain a challenge for many physicians. The result, too often, is unnecessary testing and referrals, and in some cases unnecessary anxiety for physicians, patients, and parents. Objectives After completing this article, readers should be able to: 1. Recognize the common clinical symptoms and signs of systemic lupus erythematosus, dermatomyositis, and scleroderma, and their distinction from common infectious mimics. 2. Recognize the testing that can clarify the likelihood of whether a child has a rheumatic disease, including the limited utility of early serologic testing for autoantibodies. 3. Recognize the prognosis and management objectives for these often-chronic disorders, and practical steps to ensure excellent outcomes.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 501-515 |
| Number of pages | 15 |
| Journal | Pediatrics in review |
| Volume | 39 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 2018 |
Bibliographical note
Publisher Copyright:© 2018 American Academy of Pediatrics. All rights reserved.
Fingerprint
Dive into the research topics of 'Collagen vascular diseases: SLE, dermatomyositis, scleroderma, and MCTD'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS